License and Collaboration Agreements (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024
Innoviva Inc. | SUL-DUR
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Milestone payment made		$ 8.0
Maximum additional milestone payments	$ 80.6
BMS | Repotrectinib
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Milestone payment made		$ 25.0
Maximum additional milestone payments	116.0
BMS | Xanomeline-Trospium Chloride
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Milestone payment made	10.0
Maximum additional milestone payments	132.0
Other Counterparties
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Payment of upfront fees for license agreement	$ 12.0